poxvirus
doublestrand
dna
virus
replic
entir
cytoplasm
largest
known
anim
virus
famou
member
poxviru
famili
variola
viru
caus
agent
smallpox
vaccinia
viru
share
amino
acid
sequenc
ident
variola
use
variola
viru
vaccin
wide
use
model
poxviru
laboratori
smallpox
devast
highli
transmiss
infecti
diseas
high
morbid
mortal
follow
global
intens
immun
campaign
vaccinia
viru
vaccin
world
health
organ
declar
worldwid
erad
smallpox
three
year
later
variola
viru
stock
either
supposedli
destroy
submit
one
two
whoapprov
laboratori
situat
us
center
diseas
control
prevent
cdc
atlanta
russian
state
research
center
virolog
biotechnolog
novosibirsk
success
global
immun
campaign
result
decreas
demand
develop
therapi
variola
viru
pharmaceut
compani
littl
interest
develop
drug
diseas
alreadi
erad
howev
owe
recent
worldwid
polit
develop
variola
nowaday
wide
regard
one
signific
bioterrorist
threat
fact
cdc
place
variola
viru
top
highthreat
agent
list
categori
impact
smallpox
pandem
human
popul
today
would
even
catastroph
last
centuri
result
vaccin
program
suspend
mainli
vaccinia
viru
vaccin
substanti
side
effect
moreov
also
natur
public
threat
aris
emerg
zoonot
poxviru
infect
monkeypox
viru
viru
produc
diseas
man
close
resembl
smallpox
though
less
frequent
fatal
monkeypox
exist
natur
africa
sever
case
report
us
everi
year
bioterrorist
threat
grow
concern
zoonot
infect
side
effect
vaccin
reestablish
need
effici
safe
therapi
poxviru
infect
recent
sever
compound
identifi
inhibit
variou
step
poxviru
infect
includ
dna
synthesi
virion
morphogenesi
drug
current
recommend
shortterm
prophylaxi
advers
vaccin
reaction
emerg
treatment
smallpox
cidofovir
cdv
tecovirimat
figur
cdv
acycl
phosphon
deriv
cytosin
target
viral
dna
polymeras
broadspectrum
antivi
synthesi
antivir
activ
seri
novel
polycycl
analogu
orthopoxviru
egress
inhibitor
tecovirimat
present
sever
compound
display
submicromolar
activ
vaccinia
viru
potent
cidofovir
cdv
activ
compound
activ
cdv
minimum
cytotox
concentr
mm
chemic
manipul
two
carboncarbon
doubl
bond
present
compound
carri
explor
structureact
relationship
new
polycycl
imid
hydrogen
two
carboncarbon
doubl
bond
decreas
antivir
activ
wherea
either
cyclopropan
epoxid
doubl
bond
fulli
elimin
antivir
activ
ral
activ
prove
effect
mani
poxvirus
herpesvirus
howev
low
oral
bioavail
cdv
potenti
nephrotox
associ
intraven
administr
would
issu
case
bioterrorist
attack
prodrug
cdv
prepar
significantli
enhanc
oral
bioavail
tecovirimat
new
potent
oral
activ
antipoxvir
agent
recent
disclos
siga
laboratori
featur
polycycl
hydrocarbon
moieti
nbenzamido
substitu
target
protein
vaccinia
viru
membran
compon
requir
format
extracellular
viral
particl
tecovirimat
shown
inhibit
growth
multipl
orthopoxvirus
cell
cultur
includ
two
strain
variola
viru
addit
tecovirimat
demonstr
signific
antivir
activ
variou
anim
model
poxviru
diseas
includ
complet
protect
goldenmantl
ground
squirrel
lethal
dose
monkeypox
viru
protect
nonhuman
primat
variola
viru
lesion
diseas
model
agent
demonstr
favor
safeti
toler
pharmacokinet
doubleblind
random
placebocontrol
phase
ascendingdos
studi
healthi
human
volunt
result
support
use
tecovirimat
prevent
smallpox
diseas
nonvaccin
individu
postexposur
therapeut
use
nonsymptomat
individu
expos
variola
viru
treatment
confirm
smallpox
infect
adjuv
vaccin
smallpox
vaccin
recent
receiv
orphan
drug
design
fasttrack
statu
us
food
drug
administr
fda
support
develop
tecovirimat
prevent
treatment
smallpox
infect
siga
disclos
structureact
relationship
mainli
regard
effect
substitut
aromat
ring
howev
effort
made
regard
replac
tricyclononen
subunit
figur
result
discuss
mani
year
group
work
synthesi
polycycl
hydrocarbon
deriv
mainli
synthet
orient
point
view
believ
replac
tricyclononan
subunit
polycycl
hydrocarbon
structur
could
lead
new
compound
potenti
antipoxvir
activ
dimethyl
pentacyclo
function
polycycl
compound
easili
avail
cyclopentadien
dimethyl
acetylenedicarboxyl
follow
onepot
procedur
year
compound
start
materi
synthesi
sever
theoret
interest
polycycl
compound
dodecahedran
c
hexaquinacen
function
bisnoradamantan
deriv
triquinacen
deriv
herein
report
synthesi
potent
antivir
activ
sever
analogu
contain
pentacyclo
moieti
best
knowledg
first
biolog
activ
compound
featur
pentacycl
framework
also
report
synthesi
evalu
sever
analogu
contain
tricyclo
octan
bisnoradamant
skeleton
note
although
sever
analogu
studi
siga
two
carbonyl
group
imid
moieti
molecul
attach
methyn
carbon
atom
compound
herein
featur
carbonyl
group
attach
quaternari
carbon
atom
figur
synthesi
compound
aj
accomplish
two
step
condens
acyl
hydrazid
known
bisnoradamantan
anhydrid
follow
thermal
induc
dehydrat
carboxyl
acid
aj
nbenzamido
imid
aj
scheme
hand
start
diester
hydrolysi
dehydrat
led
anhydrid
high
yield
reaction
seri
acyl
hydrazid
ethanol
led
correspond
mixtur
acid
benzamido
imid
heat
mixtur
toluen
xylen
reflux
h
led
requir
imid
good
overal
yield
scheme
explor
structureact
relationship
sar
new
polycycl
imid
carri
chemic
manipu
stereoselect
epoxid
reaction
unequivoc
establish
xray
crystallographi
figur
catalyt
hydrogen
led
respect
nearli
quantit
yield
reduct
two
carboncarbon
doubl
bond
b
accompani
hydrogenolysi
bond
lead
e
quantit
yield
final
explor
doubl
cyclopropan
dien
sever
attempt
achiev
cyclopropan
fail
carri
cyclopropan
anhydrid
led
anhydrid
reaction
select
acyl
hydrazid
follow
thermal
induc
dehydrat
carboxyl
acid
led
nbenzamido
imid
k
l
p
good
overal
yield
scheme
stereoselect
cyclopropan
reaction
unequivoc
establish
xray
crystallographi
figur
structur
new
compound
confirm
element
analysi
andor
accur
mass
measur
well
ir
h
nmr
c
nmr
mass
spectral
data
moreov
structur
featur
e
confirm
xray
crystallographi
figur
interestingli
e
plane
benzamido
substitu
essenti
orthogon
plane
imid
group
compound
gener
structur
cpe
cytopath
effect
reduct
assay
perform
determin
antivir
activ
broad
panel
dna
rna
virus
herp
simplex
viru
type
type
vaccinia
viru
evalu
infect
human
embryon
lung
fibroblast
hel
cell
felin
coronaviru
felin
herpesviru
crandellre
felin
kidney
cell
vesicular
stomat
viru
coxsacki
viru
respiratori
syncytium
viru
test
hela
cell
viru
sindbi
viru
punta
toro
viru
test
vero
cell
influenza
viru
madindarbi
canin
kidney
cell
studi
sar
sever
analogu
bailey
et
al
previous
found
electronwithdraw
substi
wwwchemmedchemorg
tution
meta
para
posit
nbenzamido
substitu
provid
potent
inhibitor
orthopoxviru
observ
trend
bisnoradamantan
deriv
pnitro
c
f
deriv
activ
compound
vaccinia
viru
tabl
reason
synthes
deriv
electronwithdraw
substitu
benzamid
ring
two
carboncarbon
doubl
bond
shown
essenti
good
antivir
activ
neither
epoxid
cyclopropan
deriv
activ
data
shown
hydrogen
also
decreas
potenc
reduc
compound
one
order
magnitud
less
potent
dien
interestingli
within
dien
although
deriv
para
substitut
one
electronwithdraw
group
activ
vaccinia
viru
low
micromolar
order
introduct
electronwithdraw
group
meta
posit
led
submicromolar
activ
activ
compound
k
l
show
submicromolar
ec
valu
least
time
lower
cidofovir
howev
electronwithdraw
substitu
meta
posit
less
potent
compound
found
compar
r
interestingli
compound
show
cytotox
determin
microscopi
highest
concentr
test
hel
cell
mm
none
compound
display
consider
activ
defin
antivir
ec
valu
mm
less
virus
test
synthes
seri
nbenzamido
imid
test
vaccinia
viru
although
bisnoradamantan
deriv
either
inact
activ
high
micromolar
concentr
pentacyclo
deriv
show
low
micromolar
submicromolar
antivaccinia
viru
activ
activ
compound
activ
cidofovir
minimum
cytotox
concentr
mm
hydrogen
two
carboncarbon
doubl
bond
decreas
antivir
activ
wherea
either
cyclopropan
epoxid
doubl
bond
fulli
elimin
antivir
activ
synthesi
mixtur
anhydrid
mg
mmol
acid
hydrazid
mg
mmol
drop
diisopropylethylamin
absolut
etoh
ml
heat
reflux
h
upon
cool
room
temperatur
h
ml
ad
precipit
collect
filtrat
wash
cold
etoh
ml
give
compound
white
solid
ch
ch
n
n
f
r
k
r
h
n
l
r
h
n
r
h
n
n
r
h
n
r
c
h
n
p
r
n
q
r
h
n
r
r
c
h
n
r
c
h
r
h
u
r
h
n
r
c
h
n
e
r
c
ch
q
j
hz
ch
c
q
j
hz
c
c
arco
c
cooh
ppm
c
ir
kbr
max
ch
ch
c
q
j
hz
cf
ch
q
j
hz
ch
c
q
j
hz
c
c
arconh
ppm
c
ir
kbr
compound
bi
prepar
similar
manner
full
experiment
data
compound
given
support
inform
synthesi
j
mixtur
acetohydrazid
mg
mmol
anhydrid
mg
mmol
drop
diisopropylethylamin
absolut
etoh
ml
heat
reflux
h
upon
cool
room
temperatur
h
ml
ad
solut
occasion
suspens
store
refriger
overnight
precipit
collect
filtrat
wash
cold
etoh
ml
solid
suspend
xylen
ml
heat
reflux
h
deanstark
apparatu
solut
concentr
vacuo
give
compound
